As of 2025-05-22, the EV/EBITDA ratio of Core Laboratories NV (CLB) is 8.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLB's latest enterprise value is 623.57 mil USD. CLB's TTM EBITDA according to its financial statements is 72.50 mil USD. Dividing these 2 quantities gives us the above CLB EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 5.3x | 5.2x |
| Forward P/E multiples | 5.1x - 6.4x | 5.7x |
| Fair Price | 4.65 - 8.37 | 6.47 |
| Upside | -58.1% - -24.7% | -41.8% |
| Date | EV/EBITDA |
| 2025-05-21 | 8.60 |
| 2025-05-20 | 8.81 |
| 2025-05-19 | 8.92 |
| 2025-05-16 | 9.07 |
| 2025-05-15 | 9.09 |
| 2025-05-14 | 9.29 |
| 2025-05-13 | 9.47 |
| 2025-05-12 | 9.21 |
| 2025-05-09 | 8.92 |
| 2025-05-08 | 8.59 |
| 2025-05-07 | 8.91 |
| 2025-05-06 | 9.03 |
| 2025-05-05 | 9.20 |
| 2025-05-02 | 9.39 |
| 2025-05-01 | 8.96 |
| 2025-04-30 | 8.76 |
| 2025-04-29 | 8.99 |
| 2025-04-28 | 8.72 |
| 2025-04-25 | 9.08 |
| 2025-04-24 | 8.92 |
| 2025-04-23 | 9.22 |
| 2025-04-22 | 9.45 |
| 2025-04-21 | 9.34 |
| 2025-04-17 | 9.57 |
| 2025-04-16 | 9.38 |
| 2025-04-15 | 9.16 |
| 2025-04-14 | 9.27 |
| 2025-04-11 | 9.29 |
| 2025-04-10 | 9.10 |
| 2025-04-09 | 9.64 |
| 2025-04-08 | 8.27 |
| 2025-04-07 | 9.00 |
| 2025-04-04 | 9.18 |
| 2025-04-03 | 10.10 |
| 2025-04-02 | 11.06 |
| 2025-04-01 | 11.10 |
| 2025-03-31 | 11.10 |
| 2025-03-28 | 11.32 |
| 2025-03-27 | 11.45 |
| 2025-03-26 | 11.36 |
| 2025-03-25 | 11.46 |
| 2025-03-24 | 11.47 |
| 2025-03-21 | 11.32 |
| 2025-03-20 | 11.37 |
| 2025-03-19 | 11.36 |
| 2025-03-18 | 11.23 |
| 2025-03-17 | 11.04 |
| 2025-03-14 | 11.26 |
| 2025-03-13 | 10.92 |
| 2025-03-12 | 11.16 |